Simultaneous effective treatment of critical COVID-19 disease and newly diagnosed high-risk multiple myeloma with thalidomide, methylprednisolone, tocilizumab and baricitinib: is it clinically feasible?
Minerva Med. 2021 Dec 3.
doi: 10.23736/S0026-4806.20.07050-0.
Online ahead of print.
1 South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus, Budapest, Hungary - szabo.balint.gergely@gmail.com.
2 School of PhD Studies, Semmelweis University, Budapest, Hungary - szabo.balint.gergely@gmail.com.
3 South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus, Budapest, Hungary.